Clinical Pharmacokinetics of Lofexidine, the α 2-Adrenergic Receptor Agonist, in Opiate Addicts Plasma Using a Highly Sensitive Liquid Chromatography Tandem Mass Spectrometric Analysis

Elmer Yu University of Pennsylvania and Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA

Karen Miotto University of California at Los Angeles and Long Beach Veterans Affairs Medical Center, Los Angeles, California, USA

Evaristo Akerele Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute, New York, New York, USA

Charles P. O'Brien University of Pennsylvania and Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA

Walter Ling University of California at Los Angeles and Long Beach Veterans Affairs Medical Center, Los Angeles, California, USA

Herbert Kleber Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute, New York, New York, USA

Marian W. Fischman Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute, New York, New York, USA

Ahmed Elkashef Division of Pharmacotherapeutics and Medical Consequences of Drug Abuse (PMC), National Institute on Drug Abuse (NIDA), National Institute of Health (NIH), Bethesda, Maryland, USA

Barbara H. Herman Division of Pharmacotherapeutics and Medical Consequences of Drug Abuse (PMC), National Institute on Drug Abuse (NIDA), National Institute of Health (NIH), Bethesda, Maryland, USA

Abeer M. Al-Ghananeem Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA

show all

REFERENCES

Kahn A, Mumford J P, Ash-Rogers G, Beckford H. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts. Drug Alcohol Depend 1997; 44: 57–61
PubMed Web of Science ®Google Scholar
Charney D S, Sternberg D E, Kleber H D, Heninger G R, Redmond D E. The clinical use of clonidine in abrupt withdrawal from methadone: effects on blood pressure and specific signs and symptoms. Arch Gen Psychiatr 1981; 38: 273–277
Google Scholar
Gossop M. Clonidine and the treatment of the opiate withdrawal syndrome. Drug Alcohol Depend 1988; 21: 253–259
PubMed Web of Science ®Google Scholar
Bearn J, Gossop M, Strang J. Randomized double blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal. Drug Alcohol Depend 1996; 43: 87–89
PubMed Web of Science ®Google Scholar
Lin S K, Strang J, Su L W, Tsai C J, Hu W M. Double-blind randomized controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal. Drug Alcohol Depend 1997; 48: 127–133
PubMed Web of Science ®Google Scholar
Wylie A S, Stewart A M. Lofexidine based regimen for opiate addicts. Br J Gen Pract 1995; 45(393)217–218
PubMedGoogle Scholar
Midgley I, Chasseaud L F, Taylor T, Darragh A. The absorption and excretion of 14C-lofexidine hydrochloride in man. Arzneimittel-Forschung 1982; 32: 972–975
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinical Pharmacokinetics of Lofexidine, the α 2-Adrenergic Receptor Agonist, in Opiate Addicts Plasma Using a Highly Sensitive Liquid Chromatography Tandem Mass Spectrometric Analysis

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical Pharmacokinetics of Lofexidine, the α 2-Adrenergic Receptor Agonist, in Opiate Addicts Plasma Using a Highly Sensitive Liquid Chromatography Tandem Mass Spectrometric Analysis

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date